Home › Merck Raises 2013 Profit Forecast on Progress in Cost Cuts
 

Keywords :   


Merck Raises 2013 Profit Forecast on Progress in Cost Cuts

2013-11-15 02:03:46| Biotech - Topix.net

Merck KGaA, the German maker of the cancer drug Erbitux, raised its profit forecast for the year as cost reductions are taking effect faster than planned.

Tags: cost progress profit cuts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10MCC acquires smart label solutions provider Starport Technologies
07.10UPM Raflatac announces Packaging Recyclability Guide
07.10Sun Chemical issues new sustainability report
07.10Hurricane Milton Public Advisory Number 10
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Forecast Discussion Number 21
07.10Hurricane Leslie Wind Speed Probabilities Number 21
07.10Hurricane Leslie Forecast Advisory Number 21
More »